Zimmer Biomet (ZBH) President APAC Chintan Desai Receives RSU Award

What Happened
Chintan Desai, President, APAC for Zimmer Biomet Holdings, Inc. (ZBH), received a grant of 10,168 restricted stock units (RSUs) on August 3, 2026. The grant is reported as a derivative award (code A) with an acquisition price of $0.00 — RSUs represent a contingent right to receive common stock rather than an immediate share purchase.

Key Details

• Transaction date: 2026-08-03; Report filed: 2026-08-05 (timely filing within the required period).
• Grant: 10,168 RSUs at $0.00 (derivative award).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — each RSU converts to one share when vested. F2 — vesting schedule: one-third vests Aug 3, 2027; one-third Aug 3, 2028; one-third Aug 3, 2029.
• Transaction code: A (award/grant).

Context
RSUs are a common form of executive compensation and only convert into actual shares upon vesting, so this grant does not represent an immediate open‑market purchase or sale. Because the award has a multi‑year vesting schedule, its impact on share count and potential insider selling is spread over future dates.